CRYSTAL HOWLETT: Open Payments
NPI 1659045805 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,026 in 102 payments from 17 companies in 2025. Trend: 2023 $348 · 2024 $835 · 2025 $4,026
Consulting: $2,300Food & beverage: $1,464Travel & lodging: $262
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $2,591 |
| ANI Pharmaceuticals, Inc. | 17 | $204 |
| AstraZeneca Pharmaceuticals LP | 4 | $198 |
| Vanda Pharmaceuticals Inc. | 8 | $171 |
| ABBVIE INC. | 15 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $153 |
| Amgen Inc. | 11 | $140 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Mallinckrodt Hospital Products Inc. | 2 | $61 |
| Axsome Therapeutics, Inc. | 2 | $40 |
Products named: MOUNJARO, PURIFIED CORTROPHIN GEL, AIRSUPRA, HETLIOZ, VRAYLAR, CAPLYTA, OTEZLA, REXULTI.
Industry payments across KY — which companies pay providers there.
